Skip to content

The Use of Social Media Platform to Continuously Support Pregnant Women With Gestational Diabetes Mellitus

The Acceptability and Feasibility of Using a Social Media Platform to Provide Continuous Support in the Follow-up Management of Gestational Diabetes: A Pilot Randomised Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06292871
Enrollment
40
Registered
2024-03-05
Start date
2024-04-30
Completion date
2025-03-31
Last updated
2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes

Keywords

Maternal Behaviour, Mobile Health, Blood Glucose, Emotional Wellbeing, Engagement

Brief summary

To assess the efficacy of utilizing a social media platform for dietary and lifestyle management in improving acceptance and blood glucose control in patients with gestational diabetes mellitus (GDM), compared to the control group under usual care. Specifically, i. To measure the participants' acceptability and satisfaction levels of receiving intervention through the social media platform. ii. To measure the feasibility of using the social media platform to provide GDM support through participants' engagement levels and feedback questionnaire. iii. To measure the efficacy of using the social media platform to manage emotional responses in women with GDM. iv. To measure the efficacy of using the social media platform to optimize glycemic control in women with GDM.

Detailed description

Engaging pregnant women with GDM in dietary management over the gestation has been challenging. This pilot trial aims to assess the efficacy of utilizing a social media platform for dietary and lifestyle management in improving acceptance and blood glucose control among patients with GDM, compared to a control group receiving usual care. The study will employ a randomized controlled trial design, with GDM patients from KK Women's and Children's Hospital (KKH) randomly assigned to either the usual care (control; n=40) or to additional support via a dedicated social media platform for a period of 1 month, where a moderator will be available to address patients' queries and share relevant educational resources (intervention; n=40). Outcome measures include acceptance, satisfaction, and engagement levels, emotional well-being as well as the percentage achievement of time-in-range glucose readings for GDM patients. The independent t-test will be used to compare the outcome measures between groups. The findings from this study will provide valuable insights into the feasibility and efficacy of incorporating digital platforms into routine dietary counselling practices for improved patient outcomes and enhanced management of GDM.

Interventions

BEHAVIORALAdditional GDM management through social media

Usual care provided by a diabetes nurse educator and dietitian. Additional educational resources for dietary management care received, and for any queries to be addressed by dietitian via social media platform from baseline to one-month follow-up visit.

BEHAVIORALUsual care

Usual care provided by a diabetes nurse educator and dietitian.

Sponsors

KK Women's and Children's Hospital
Lead SponsorOTHER_GOV
Singapore Institute of Technology
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

The study will employ a randomized controlled trial design, with GDM patients from KKH randomly assigned to either the intervention or control group. Randomization will be conducted via the electronic randomization list.

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with GDM as confirmed by the Oral Glucose Tolerance Test during pregnancy * Age ≥ 21 and ≤ 45 years * Attended first (baseline) session of GDM diet counselling session * Able to read and comprehend English * Have a digital device accessible to social media platform * Have SingPass access * Able to provide informed consent

Exclusion criteria

* With known Type 1 or Type 2 diabetes * Have multiple pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Acceptance levelsAt the end of one month from baseline visitAssessed by a 5-point Likert-type scale, ranging from 1 (completely disagree) to 5 (completely agree). A higher score indicates a higher acceptance level.
Satisfaction levelsAt the end of one month from baseline visitAssessed by a 5-point Likert-type scale, ranging from 1 (completely disagree) to 5 (completely agree). A higher score indicates a higher satisfaction level.

Secondary

MeasureTime frameDescription
Engagement levelsAt the end of one month from baseline visitAssessed by frequency of interactions with the platform moderator and frequency of platform visits among women in the intervention group
Appropriateness levelsAt the end of one month from baseline visitAssessed by a 5-point Likert-type scale, ranging from 1 (completely disagree) to 5 (completely agree). A higher score indicates a greater appropriateness level.
Feasibility levelsAt the end of one month from baseline visitAssessed by a 5-point Likert-type scale, ranging from 1 (completely disagree) to 5 (completely agree). A higher score indicates a higher feasibility level.
Emotional wellbeingAt the end of one month from baseline visitAssessed by the Perceived Stress Scale on a 5-point Likert-type scale, ranging from 0 (never) to 4 (very often). A higher score indicates a higher perceived stress level.
Blood glucose levelsAt the end of one month from baseline visitAssessed by finger prick tests, in mmol/L
Proportion of participants with optimal blood glucose controlAt the end of one month from baseline visitBased on recommended pre-meal range of 4.4-5.5 mmol/L and 2h post-meal range of 5.5-6.6 mmol/L

Countries

Singapore

Contacts

PRINCIPAL_INVESTIGATORWee Meng Han, PhD

KK Women's and Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026